Precision medicine and drug repositioning

Sponsored By 

Session Chair & Speaker - WITH Funding(s)

• 

  Krister Wennerberg, PhD (he/him/his)

  Professor
  University of Copenhagen
  Copenhagen, Hovedstaden, Denmark

Speaker - Funded(s)

• 

  Donald C. Lo, PhD (he/him/his)

  Director for Medicines Development
  EATRIS
  Amsterdam, Noord-Holland, Netherlands

Speaker - Not Funded(s)

• 

  Jaime Cheah, PhD (she/her/hers)

  Director of Collaborative Screening
  Broad Institute of MIT and Harvard
  Cambridge, Massachusetts, United States

In this session, we will explore how personalized medicine and drug repositioning enhance drug discovery pipeline productivity. We'll discuss the current research status in these areas, covering techniques and challenges.

Presentations:

• 14:30 – 15:00 CEST

  Precision targeting of drug resistance in primary cancer cell models
  

  Krister Wennerberg, PhD (he/him/his) – University of Copenhagen
• 15:00 – 15:30 CEST

  The Broad Institute Repurposing Hub: a Small Molecule Toolbox for Interrogating Biological Pathways in Disease Models
  

  Jaime Cheah, PhD (she/her/hers) – Broad Institute of MIT and Harvard
• 15:30 – 16:00 CEST

  International collaboration is key for successful patient-centric drug repurposing and repositioning
  

  Donald C. Lo, PhD (he/him/his) – EATRIS